NCT02018796View on ClinicalTrials.gov

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan

CompletedOBSERVATIONAL
Enrollment

290

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Complete Abortion
Interventions
DRUG

Mifepristone, misoprostol

200 mifepristone, followed 24 to 48 hours later by 600 mcg misoprostol

Trial Locations (4)

Unknown

Almaty City Policlinic No. 19, Almaty

Almaty City Policlinic No. 9, Almaty

Consultation and Diagnostics Department of the City Maternity House, Astana

Consultation and Diagnostics Department of the Regional Perinatal Center No. 2, Astana

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT02018796 - Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan | Biotech Hunter | Biotech Hunter